Author's posts
LifePoint shareholders approve RCCH deal
LifePoint Health’s shareholders voted Monday to approve the proposed sale of the investor-owned hospital operator to affiliates of Apollo Global Management. LifePoint expects the deal to close by year-end.
MetroHealth takes multifaceted stance in opioid battle
As the opioid epidemic claims the lives of tens of thousands of Americans every year, Cleveland’s MetroHealth has been fortifying its battle against the crisis, accelerating its work within the past couple of years.
Cleveland Clinic-Case venture can ‘reduce silos’ between medical, dental and nursing students
Cleveland Clinic has a lofty goal for a new building on its main campus: to revolutionize healthcare education as we know it.
Q&A: Providence St. Joseph’s Venkat Bhamidipati on consumer-centric approach, tech
Venkat Bhamidipati, Providence St. Joseph’s CFO, brings decades of expertise from the tech world into healthcare at a time when rapid technological advances and shifts in consumer demand are transforming care delivery.
As billions in tax dollars flow to private Medicaid plans, who’s minding the store?
Are insurers — now receiving hundreds of billions in public money — earning their Medicaid checks? When auditors, lawmakers and regulators bother to look, many conclude that Medicaid insurers fail to account for the dollars spent or deliver…
Commentary: Abuse of U.S. patent system drives high drug prices
The abuse and misuse of the patent system by drugmakers needs to stop, and patients and consumer advocates deserve more say in the patent system.
Week Ahead: Aetna, Anthem expected to continue positive earnings news
Several heavy hitters deliver their earnings results this week, including insurers Aetna and Anthem, both of which are expected to build on positive results from the prior quarter.
Centralizing sterilization: Inside Northwell Health’s new facility
Northwell Health is poised to open what it’s calling the world’s largest medical sterilization center this month. The $80 million facility will clean 22 million instruments per year.
Will Trump’s push for flexibility help revamp insurance markets?
Observers are divided over whether the Trump administration’s moves to allow states to sidestep certain aspects of the Affordable Care Act will ultimately harm the marketplace and the vulnerable people who shop for coverage there.
Fate of Trump’s Part B drug cost plan may depend on Dems winning House
Trump’s Medicare Part B drug cost plan could move forward, particularly if Democrats win control of the House.
